The companies are now moving forward with the import permit application process.Following expected approval of the import permit, Red Light…
New York, New York--(Newsfile Corp. - April 15, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM) ("Psyence BioMed" or the "Company")…
Dr. Chung brings expertise in scaling medical teams to Ezra’s mission of making early cancer detection accessible to everyone Dr.…
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with…
CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology…
Study Highlights Critical Influence of AI-Driven Reputation on Pharma Market Leaders and New EntrantsCAMPBELL, Calif. and NEW YORK, April 15,…
ELYXYB® is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or…
LOUISVILLE, Ky., April 15, 2025 (GLOBE NEWSWIRE) -- Confluent Health, a nationwide network of physical and occupational therapy companies, recently…
Veteran Oncologist and Clinical Development expert to lead global medical strategy supporting patient-focused drug development and deliveryDURHAM, N.C., April 15,…
The global healthtech market is experiencing rapid growth due to increasing health awareness and preventive care and the surge in…